Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Type:  Review
Policy:  Open

Results 1-20 of 40 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
12018A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugsWong, A.L.-A ; Xiang, X; Ong, P.S ; Mitchell, E.Q.Y; Syn, N; Wee, I; Kumar, A.P ; Yong, W.P ; Sethi, G ; Goh, B.C ; Ho, P.C.-L ; Wang, L 
22018Antioxidant response elements: Discovery, classes, regulation and potential applicationsRaghunath, A.; Sundarraj, K.; Nagarajan, R.; Arfuso, F.; Bian, J. ; Kumar, A.P. ; Sethi, G. ; Perumal, E.
32019Autophagy modulators: Mechanistic aspects and drug delivery systemsTavakol, S.; Ashrafizadeh, M.; Deng, S. ; Azarian, M.; Abdoli, A.; Motavaf, M.; Poormoghadam, D.; Khanbabaei, H.; Ghasemipour Afshar, E.; Mandegary, A.; Pardakhty, A.; Yap, C.T. ; Mohammadinejad, R.; Prem Kumar, A. 
41-May-2023Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiformeLim, Xin Yuan; Capinpin, Sharah Mae ; Bolem, Nagarjun; Foo, Aaron Song Chuan; Yip, Wai-Cheong George ; Kumar, Alan Prem ; Teh, Daniel Boon Loong 
527-Sep-2020Broad-spectrum preclinical antitumor activity of chrysin: Current trends and future perspectivesMoghadam, E.R.; Ang, H.L.; Asnaf, S.E.; Zabolian, A.; Saleki, H.; Yavari, M.; Esmaeili, H.; Zarrabi, A.; Ashrafizadeh, M.; Kumar, A.P. 
61-Jan-2023Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent TrendsTuli, Hardeep Singh; Rath, Prangya; Chauhan, Abhishek; Ranjan, Anuj; Ramniwas, Seema; Sak, Katrin; Aggarwal, Diwakar; Kumar, Manoj; Dhama, Kuldeep; Lee, E Hui Clarissa ; Yap, Kenneth Chun-Yong; Capinpin, Sharah Mae ; Kumar, Alan Prem 
71-Apr-2021Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer MetastasisDatta, Arpita ; Deng, Shuo ; Gopal, Vennila; Yap, Kenneth Chun-Hong ; Halim, Clarissa Esmeralda ; Lye, Mun Leng; Ong, Mei Shan ; Tan, Tuan Zea ; Sethi, Gautam ; Hooi, Shing Chuan ; Kumar, Alan Prem ; Yap, Celestial T 
81-Sep-2022Demystifying the Functional Role of Nuclear Receptors in Esophageal CancerJayaprakash, Sujitha; Hegde, Mangala; Girisa, Sosmitha; Alqahtani, Mohammed S; Abbas, Mohamed; Lee, E Hui Clarissa ; Yap, Kenneth Chun-Hong ; Sethi, Gautam ; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B
93-Apr-2022Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: Stimuli-responsive carriers, co-delivery and suppressing resistanceM Ashrafizadeh; Hamidreza Saebfar; Mohammad Hossein Gholami; Kiavash Hushmandi; Amirhossein Zabolian; Pooria Bikarannejad; Mehrdad Hashemi; Salman Daneshi; Sepideh Mirzaei; Esmaeel Sharifi; Alan Kumar ; Haroon Khan; Hamid Heydari Sheikh Hossein; Massoud Vosough; Navid Rabiee; Vijay Kumar Thakur; Pooyan Makvandi; Yogendra Mishra; Franklin Tay; Yuzhuo Wang; Ali Zarrabi; Gorka Orive; Ebrahim Mostafavi
1020-Oct-2021Editing SOX genes by CRISPR-cas: Current insights and future perspectivesDehshahri, Ali; Biagioni, Alessio; Bayat, Hadi; Lee, E. Hui Clarissa ; Hashemabadi, Mohammad; Fekri, Hojjat Samareh; Zarrabi, Ali; Mohammadinejad, Reza; Kumar, Alan Prem 
1128-Jun-2022Emerging role of exosomes in cancer progression and tumor microenvironment remodelingPaskeh, Mahshid Deldar Abad; Entezari, Maliheh; Mirzaei, Sepideh; Zabolian, Amirhossein; Saleki, Hossein; Naghdi, Mohamad Javad; Sabet, Sina; Khoshbakht, Mohammad Amin; Hashemi, Mehrdad; Hushmandi, Kiavash; Sethi, Gautam ; Zarrabi, Ali; Kumar, Alan Prem ; Tan, Shing Cheng; Papadakis, Marios; Alexiou, Athanasios; Islam, Md Asiful; Mostafavi, Ebrahim; Ashrafizadeh, Milad
121-Jan-2022Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic ComplicationsAshrafizadeh, M; Kumar, AP ; Aref, AR; Zarrabi, A; Mostafavi, E
132019FBXW7 in cancer: What has been unraveled thus far?Sailo, B.L.; Banik, K.; Girisa, S.; Bordoloi, D.; Fan, L. ; Halim, C.E. ; Wang, H. ; Kumar, A.P. ; Zheng, D.; Mao, X.; Sethi, G. ; Kunnumakkara, A.B.
141-Nov-2021Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppressionAshrafizadeh, Milad; Mirzaei, Sepideh; Gholami, Mohammad Hossein; Hashemi, Farid; Zabolian, Amirhossein; Raei, Mehdi; Hushmandi, Kiavash; Zarrabi, Ali; Voelcker, Nicolas H.; Aref, Amir Reza; Hamblin, Michael R.; Varma, Rajender S.; Samarghandian, Saeed; Arostegi, I. J.; Alzola, M.; Kumar, Alan Prem ; Thakur, Vijay Kumar; Nabavi, Noushin; Makvandi, Pooyan; Tay, Franklin R.; Orive, Gorka
15May-2019Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseasesMishra, Shruti; Verma, Sumit S; Rai, Vipin; Awasthee, Nikee; Chava, Srinivas; Hui, Kam Man; Kumar, Alan Prem ; Challagundla, Kishore B; Sethi, Gautam ; Gupta, Subash C
162018Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancerRanaware A.M.; Banik K.; Deshpande V.; Padmavathi G.; Roy N.K.; Sethi G. ; Fan L.; Kumar A.P. ; Kunnumakkara A.B.
171-Dec-2022Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for interventionMirzaei, S; Paskeh, MDA; Okina, E ; Gholami, MH; Hushmandi, K; Hashemi, M; Kalu, A; Zarrabi, A; Nabavi, N; Rabiee, N; Sharifi, E; Karimi-Maleh, H; Ashrafizadeh, M; Kumar, AP ; Wang, Y
18Feb-2012Multifaceted link between cancer and inflammationSethi, G.; Shanmugam, M.K. ; Ramachandran, L.; Kumar, A.P. ; Tergaonkar, V.
1917-Jun-2022(Nano)platforms in bladder cancer therapy: Challenges and opportunitiesAshrafizadeh, Milad; Zarrabi, Ali; Karimi-Maleh, Hassan; Taheriazam, Afshin; Mirzaei, Sepideh; Hashemi, Mehrdad; Hushmandi, Kiavash; Makvandi, Pooyan; Nazarzadeh Zare, Ehsan; Sharifi, Esmaeel; Goel, Arul; Wang, Lingzhi ; Ren, Jun; Nuri Ertas, Yavuz; Kumar, Alan Prem ; Wang, Yuzhuo; Rabiee, Navid; Sethi, Gautam ; Ma, Zhaowu
201-Sep-2021New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilitiesAshrafizadeh, Milad; Mirzaei, Sepideh; Hashemi, Farid; Zarrabi, Ali; Zabolian, Amirhossein; Saleki, Hossein; Sharifzadeh, Seyed Omid; Soleymani, Leyla; Daneshi, Salman; Hushmandi, Kiavash; Khan, Haroon; Kumar, Alan Prem ; Aref, Amir Reza; Samarghandian, Saeed